Abstract

In the context of pharmaceuticals, drug-drug interactions (DDIs) occur when two or more drugs interact, potentially altering the intended effects of the drugs and resulting in adverse patient health outcomes. Therefore, it is essential to identify and comprehend these interactions. In recent years, an increasing number of novel compounds have been discovered, resulting in the discovery of numerous new DDIs. There is a need for effective methods to extract and analyze DDIs, as the majority of this information is still predominantly located in biomedical articles and sources. Despite the development of various techniques, accurately predicting DDIs remains a significant challenge. This paper proposes a novel solution to this problem by leveraging the power of Relation BioBERT (R-BioBERT) to detect and classify DDIs and the Bidirectional Long Short-Term Memory (BLSTM) to improve the accuracy of predictions. In addition to determining whether two drugs interact, the proposed method also identifies the specific types of interactions between them. Results show that the use of BLSTM leads to significantly higher F-scores compared to our baseline model, as demonstrated on three well-known DDI extraction datasets that includes SemEval 2013, TAC 2018, and TAC 2019.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call